ABANO TERME, Italy & BALERNA, Switzerland--(BUSINESS WIRE)--Fidia Farmaceutici S.p.a. (“Fidia”) enters the Italian pediatric healthcare market with the acquisition of the HALYKOO Line developed by the Swiss-based company APR Applied Pharma Research s.a. (“APR”), specialized in the development of innovative and patent-protected products (prescription and OTC), that are marketed worldwide through licensing and distribution agreements.
Help employers find you! Check out all the jobs and post your resume.
